FDA Reportedly Denies Neuralink Request for Human Trials of its Brain Implant

  • The FDA reportedly denied Neuralink’s request to begin human trials of its brain implant.
  • Despite Elon Musk’s repeated claims, the prospects of Neuralink bringing a product to market remain distant.
  • The BCI company was apparently denied authorization by the FDA in 2022 to conduct human trials using the same devices.
  • The denial was reportedly due to the company’s practice of killing pigs.
Total
0
Shares
5/5
Join 2 million subscribers





A curated newsletter that summarizes the important news at the intersection of Global tech, India Tech and AI.

Delivered 8 AM. Daily.
Total
0
Share